Protalix BioTherapeutics, Inc. Share Price TEL AVIV STOCK EXCHANGE
Stocks
PLX
US74365A3095
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 732.50 ILa | -.--% |
|
+3.29% | +69.68% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 191M 0 168M 156M 143M 269M 18.39B 273M 1.85B 724M 9.04B 717M 701M 31.26B | P/E 2026 * |
12.2x | P/E 2027 * | 47.4x |
|---|---|---|---|---|---|
| Enterprise Value | 191M 0 168M 156M 143M 269M 18.39B 273M 1.85B 724M 9.04B 717M 701M 31.26B | EV / Sales 2026 * |
2.44x | EV / Sales 2027 * | 2.83x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protalix BioTherapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 29/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 23/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 30/06/2008 |
Aharon Schwartz
BRD | Director/Board Member | 82 | 31/10/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 29/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +3.29% | - | - | 191M | |
| +0.53% | +4.74% | +48.65% | +164.02% | 1,067B | |
| +1.49% | +7.03% | +60.21% | +53.32% | 635B | |
| +0.67% | +3.17% | +38.66% | +75.61% | 458B | |
| +1.96% | +9.10% | +38.87% | +32.83% | 347B | |
| +1.73% | +4.94% | +38.40% | +42.35% | 295B | |
| +2.08% | +4.80% | +20.24% | +21.25% | 262B | |
| +1.87% | -1.01% | -28.03% | -38.99% | 216B | |
| +1.35% | +4.52% | +26.34% | +61.25% | 203B | |
| +2.47% | -1.37% | +16.24% | +71.73% | 161B | |
| Average | +1.33% | +1.33% | +28.84% | +53.71% | 404.83B | |
| Weighted average by Cap. | +1.20% | +1.95% | +38.39% | +79.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78.3M 0 68.77M 63.95M 58.69M 110M 7.54B 112M 759M 297M 3.71B 294M 288M 12.82B | 67.56M 0 59.34M 55.19M 50.64M 95.15M 6.51B 96.62M 655M 256M 3.2B 254M 248M 11.06B |
| Net income | 15.72M 0 13.81M 12.84M 11.78M 22.14M 1.51B 22.48M 152M 59.58M 744M 59.02M 57.75M 2.57B | 4.07M 0 3.58M 3.33M 3.05M 5.74M 392M 5.83M 39.51M 15.44M 193M 15.29M 14.96M 667M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
